LEIGH PAXTON: Open Payments
NPI 1699158618 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,364 in 68 payments from 16 companies in 2025. Trend: 2023 $1,547 · 2024 $1,564 · 2025 $1,364
Food & beverage: $1,330Education: $34
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 6 | $243 |
| GENZYME CORPORATION | 18 | $241 |
| GlaxoSmithKline, LLC. | 13 | $171 |
| Novartis Pharmaceuticals Corporation | 6 | $136 |
| AstraZeneca Pharmaceuticals LP | 5 | $117 |
| Amgen Inc. | 4 | $96 |
| ABBVIE INC. | 3 | $61 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| PFIZER INC. | 3 | $59 |
| Grifols USA, LLC | 2 | $42 |
Products named: DUPIXENT, Hizentra, NUCALA, FASENRA, TEZSPIRE, RINVOQ, Rhapsido, Xembify.
Industry payments across OR — which companies pay providers there.
